The estimated Net Worth of Deborah A Griffin is at least 17 千$ dollars as of 17 March 2020. Deborah Griffin owns over 944 units of Teva- Pharmaceutical Industries stock worth over 16,954$ and over the last 7 years Deborah sold TEVA stock worth over 0$.
Deborah has made over 4 trades of the Teva- Pharmaceutical Industries stock since 2019, according to the Form 4 filled with the SEC. Most recently Deborah exercised 944 units of TEVA stock worth 16,954$ on 17 March 2020.
The largest trade Deborah's ever made was exercising 4,807 units of Teva- Pharmaceutical Industries stock on 4 March 2020 worth over 86,334$. On average, Deborah trades about 874 units every 13 days since 2018. As of 17 March 2020 Deborah still owns at least 944 units of Teva- Pharmaceutical Industries stock.
You can see the complete history of Deborah Griffin stock trades at the bottom of the page.
Deborah's mailing address filed with the SEC is C/O TEVA PHARMACEUTICAL INDUSTRIES LTD., 5 BASEL STREET, PETACH TIKVA, L3, 4951033.
Over the last 7 years, insiders at Teva- Pharmaceutical Industries have traded over 31,332,399$ worth of Teva- Pharmaceutical Industries stock and bought 967,500 units worth 16,473,820$ . The most active insiders traders include Sol J Barer、Tal Zvi Zaks、Roberto Mignone. On average, Teva- Pharmaceutical Industries executives and independent directors trade stock every 9 days with the average trade being worth of 636,538$. The most recent stock trade was executed by Varda Shalev on 2 September 2024, trading 12,872 units of TEVA stock currently worth 231,181$.
Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company with headquarters in Tel Aviv, Israel. It specializes primarily in generic drugs, but other business interests include active pharmaceutical ingredients and, to a lesser extent, proprietary pharmaceuticals.
Teva- Pharmaceutical Industries executives and other stock owners filed with the SEC include: